View Clinical Trial (Medical Research Study)

Treatment of Port-wine Mark in Sturge-Weber Syndrome Using Topical Timolol

Browse Studies

City:   Philadelphia
State:   Pennsylvania
Zip Code:   19107
Conditions:   Sturge Weber Syndrome - Port-wine Mark
Purpose:   Primary Objective: • To assess the possible utility of topical timolol in the management of port-wine mark (PWM) in Sturge-Weber syndrome in children.
Study Summary:   Port-wine mark (PWM) represents a congenital capillary malformation,characterized by dilation and malformation of dermal capillaries that lack endothelial proliferation. It is frequently seen in the facial distribution of the trigeminal nerve. PWM persists throughout life and involves ~0.3% of the population. Although PWMs are found in other circumstances, ~ 3% of patients with facial PWM are also afflicted with Sturge-Weber syndrome. PWMs are cosmetic entities that often have serious social consequences, producing psychological trauma to both children and their parents. PWM does not involute with time, and, if left untreated, can develop deep purple coloration, tissue hypertrophy, and nodularity. Laser therapy, which selectively destroys specific targets within the skin, is currently the most commonly used approach for treating PWM, although complete blanching of the PWM after laser is rarely achieved for most patients, and only 10-45% of patients with Sturge-Weber have shown satisfactory outcomes. Complications of pulsed dye laser treatment for PWM include pyogenic granuloma, scabbing, cutaneous scarring, and permanent hypo/hyperpigmentation. Laser treatment is relatively contraindicated in children with darker skin coloration due to the resulting hypopigmentation which may be equally unsightly. Laser treatment causes substantial discomfort and pain to patients, and often requires general anesthesia in children. This is particularly true since earlier treatment in infancy is desirable and yields increased successful resolution of the PWM. The hypertrophic PWM in later years is resistant to any treatment. Recently, propranolol was reported to successfully treat capillary hemangioma in infants.13 While the mechanism by which beta blockade improves hemangioma is unclear, ß2-mediated vasoconstrictive effects and the ensuing apoptosis of capillary endothelial cells may contribute to the positive therapeutic results. Oral application of propranolol can cause severe systemic complications, including bronchospasm, vasospasm, hypoglycemia, hypotension, severe bradycardia, heart block, and congestive heart failure. Topical timolol solution, a β-blocker, has shown a similar ability to reduce capillary hemangioma of eyelids with little or no systemic effects in a small pilot study. Similar to capillary hemangioma, which is a proliferative lesion characterized by increased endothelial cell turnover, PWM is a capillary malformation with abnormal endothelial cells and large surface area of dilated capillaries. Thus, both capillary hemangioma and PWM share the similar characteristic of abnormal capillary endothelial cells. This pilot study is designed to explore the potential role of topical timolol in the management of PWM. As PWM is so frequently associated with Sturge-Weber syndrome, a disorder in which approximately 50% of patients will develop glaucoma, this study will be conducted in an ophthalmology setting. This study will consist of two arms. One group will receive timolol and the second group a placebo preservative free artificial tear gel. The groups will be divided with a ratio of 1:1 and the Timolol group will be matched with the placebo group by PWM location, age and race. Both medications are to be applied and rubbed in by fingertip to the treatment site twice a day for 6 months by subject's parents/guardian. (Treatment site: 1x1 cm at inferior edge of facial PWM) Follow-up schedule: 1 week after treatment initiation and then every 2 months for a period of six months.
Criteria:   Inclusion criteria: - Age from 2 years to 10 years - Port-Wine Mark - English fluent and literate substitute decision maker - Substitute decision maker vision sufficient to read informed consent document Exclusion criteria: - Active ocular infection (conjunctivitis, keratitis,) - History of systemic conditions including hypo/hypertension, hypoglycemia, bradycardia, asthma or any contraindication to beta blocker use - Unable to comply with required follow-up - Substitute decision maker not English fluent or not literate - Substitute decision maker unable to read consent document - Patient already using systemic beta-blocker or beta-agonist (Patients already using topical beta-blocker for glaucoma will not be excluded from study).
NCT ID:   NCT01533376
Primary Contact:   Principal Investigator
Alex V Levin, MD, MHSc
Wills Eye Institute

Waleed K Abed Alnabi, MD
Phone: 2159283418
Backup Contact:   Email:
Alex V Levin, MD, MHSc
Phone: 2159283918
Location Contact:   Philadelphia, Pennsylvania 19107
United States

Waleed K Abed Alnabi, MD
Phone: 215-928-3418

Site Status: Recruiting

Data Source:
Date Processed:   February 09, 2016
Modifications to this listing:   Only selected fields are shown, please use the link below to view all information about this clinical trial.
Click to view Full Listing

If you would like to be contacted by the clinical trial representative please enter your contact information, then click I Am Interested In This Study

Full Name:
Email Address:
Confirm Email:
Daytime Phone (eg. 555-555-5555):
Zip Code:
Best Time to Call:

    (updated 57 minutes ago)
Within 25 Miles

Sleep Apnea - Philadelphia PA

Flu - Bensalem PA

Flu - Clementon NJ

Flu - Harleysville PA

Flu - Willow Grove PA

Depression - Media PA

Depression - Cherry Hill NJ

Attention Deficit Hyperactivity Disorder (ADHD) - Cherry Hill NJ

Multiple Sclerosis - Willow Grove PA

Hepatitis B - Philadelphia PA

Spinal Cord Injury - Philadelphia PA

Spinal Cord Injury - Philadelphia PA

Heart Failure - Wynnewood PA

Attention Deficit Hyperactivity Disorder (ADHD) - Media PA

Bipolar Depression - Cherry Hill NJ

Migraines - Media PA

Back Pain and Osteoarthritis - Philadelphia PA

Non-Small Cell Lung Cancer (NSCLC) - Philadelphia PA

Within 50 Miles

Pediatric Depression - Princeton NJ

Head and Neck Cancer - Bethlehem PA

Osteoarthritis - Downingtown PA

Rheumatoid Arthritis - Toms River NJ

Migraines - Toms River NJ

Migraines - Allentown PA

Healthy Volunteers - Princeton NJ

Yeast/Bacterial Vaginosis (BV) Vaginal Infections - Plainsboro NJ

Irritable Bowel Syndrome with Constipation (IBS-C) - Doylestown PA

Osteoarthritis - Trenton NJ

Within 100 Miles

Sleep Apnea - New York NY

Heart Failure - Mineola NY

Heart Failure - New York NY

Parkinson's Disease - Baltimore MD

Chronic Obstructive Pulmonary Disorder (COPD, Emphysema) - Baltimore MD

Obesity - Great Neck NY

Depression - New York NY

Healthy Female Volunteers (Age 18-50) - Baltimore MD

Multiple Sclerosis - Baltimore MD

Pediatric Depression - New York NY

Pediatric Depression - Staten Island NY

Pediatric Depression - Pikesville MD

Diabetic Foot Ulcers (Sores) - Pasadena MD

Depression - New York NY

Temporomandibular Disorder (TMJD) - Baltimore MD

Postherpetic Neuralgia - New York NY

Social Anxiety Disorder - New York NY

Adult ADHD - New York NY

Depression - New York NY

Treatment-Resistant Major Depressive Disorder - New York NY

Psoriasis - New York NY

Memory Loss - New York NY

Depression - New York NY

Spinal Cord Injury - Baltimore MD

Healthy NON-Smokers - Catonsville MD

COPD - New York NY

Adult ADHD - New York NY

Major Depressive Disorder - New York NY

Asthma in Children - Highland Park NJ

Asthma in Children - New York NY

Asthma in Children - White Marsh MD

Ischemic Stroke - Baltimore MD

Head and Neck Cancer - Baltimore MD

Head and Neck Cancer - Towson MD

Head and Neck Cancer - Bronx NY

Head and Neck Cancer - Bronx NY

Head and Neck Cancer - New Hyde Park NY

Head and Neck Cancer - Easton PA

Psoriasis - New York NY

Healthy Volunteers (Age 18-55) - Baltimore MD

Osteoarthritis - Reading PA

Cat Allergies - Baltimore MD

Healthy Male Volunteers (Age 18-50) - Baltimore MD

Healthy Volunteers (Age 18-55) - Baltimore MD

Rheumatoid Arthritis - Reading PA

Osteoarthritis - New York NY

Irritable Bowel Syndrome with Constipation (IBS-C) - Towson MD

Healthy Volunteers (Age 18-45)- Baltimore MD

Diabetes and Hypertension - New York NY

Healthy Volunteers (Age 18-65) - Baltimore MD

Healthy Volunteers (Age 18-65) - Baltimore MD

Healthy Volunteers (Age 18-55) - Baltimore MD

Healthy Volunteers (Age 18-45) - Baltimore MD

Back Pain and Osteoarthritis - New York NY

Metastatic Pancreatic Cancer - New York NY

Metastatic Pancreatic Cancer - Bronx NY

Metastatic Pancreatic Cancer - Towson MD

Asthma in Children - Bronx NY

Ulcerative Colitis - Great Neck NY

Arthritis (Rheumatoid Arthritis) - Baltimore MD

Non-Small Cell Lung Cancer (NSCLC) - Hershey PA

Healthy Volunteers (Age 18-55) - Baltimore MD

Osteoarthritis - Brooklyn NY

Heart Failure - Bridgewater NJ

Common Cold - Baltimore MD

Metastatic Pancreatic Cancer - Hershey PA

Rheumatoid Arthritis - Clifton NJ

Shingles (PHN) - Towson MD

Healthy Volunteers (Age 18-50) - Baltimore MD

Healthy Volunteers (Age 18-55) - Baltimore MD